TuisBRM • FRA
add
Bristol-Myers Squibb Co
Vorige sluiting
€55,68
Jaarwisseling
€36,46 - €58,51
Markkapitalisasie
119,32 mjd USD
Gemiddelde volume
941,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 11,89 mjd | 8,44% |
Bedryfskoste | 6,84 mjd | 7,33% |
Netto inkomste | 1,21 mjd | -37,19% |
Netto winsgrens | 10,18 | -42,09% |
Wins per aandeel | 1,80 | -10,00% |
EBITDA | 4,83 mjd | 5,53% |
Effektiewe belastingkoers | 27,51% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 8,09 mjd | 5,32% |
Totale bates | 93,67 mjd | 2,64% |
Totale aanspreeklikheid | 76,47 mjd | 22,94% |
Totale ekwiteit | 17,20 mjd | — |
Uitstaande aandele | 2,03 mjd | — |
Prys om te bespreek | 6,59 | — |
Opbrengs op bates | 5,83% | — |
Opbrengs op kapitaal | 7,86% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,21 mjd | -37,19% |
Kontant van bedrywe | 5,59 mjd | 17,68% |
Kontant van beleggings | -219,00 m | 46,59% |
Kontant van finansiering | -3,85 mjd | 25,35% |
Netto kontantverandering | 1,60 mjd | 286,35% |
Beskikbare kontantvloei | 5,59 mjd | 51,71% |
Meer oor
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
BMS's primary research and development sites are located in Lawrence, New Jersey, Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, Braine-l'Alleud, Belgium, Tokyo, Japan, Hyderabad; Bangalore, India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut. Wikipedia
Gestig
1887
Webwerf
Werknemers
34 100
